CSIMarket
 


Actavis Plc  (ACT)
Other Ticker:  
 
    Sector  Healthcare    Industry Biotechnology & Drugs
   Industry Biotechnology & Drugs
   Sector  Healthcare

Cumulative Actavis Plc's Total Debt to Equity for Trailing Twelve Months Period

ACT's Total Debt to Equity for Trailing Twelve Months Period and Total Debt, Equity growth



ACT Total Debt to Equity for Trailing Twelve Months Period

(Sep. 30, 2015)
III. Quarter
(June 30. 2015)
II. Quarter
(March 31, 2015)
I. Quarter
(Dec. 30. 2014)
IV. Quarter
(Sep. 30, 2014)
III. Quarter
Y / Y Equity Growth -87.16 % 644.54 % 641.89 % 197.06 % 678.53 %
Y / Y Total Debt Growth -59.38 % 247.65 % 408.28 % 71.72 % 146.21 %
Total Debt to Equity for Trailing Twelve Months Period 0.62 0.59 0.63 0.68 0.79
Total Ranking # 1976 # 1993 # 1959 # 1965 # 1810
Seq. Equity Growth -94.81 % 0.93 % 152.04 % -2.78 % 201.05 %
Seq. Total Debt Growth -85.28 % -3.28 % 185.16 % 0.04 % 26 %


Total Debt to Equity for Trailing Twelve Months Period Comment
On the trailing twelve months basis Despite repayements of liabilities of -85.28% in III. Quarter, Total Debt to Equity for Trailing Twelve Months Period improved to 0.62, above Actavis Plc's average Total Debt to Equity for Trailing Twelve Months Period.
Total Debt to Equity for Trailing Twelve Months Period is the average cumulative value over the last four quarters.

Among companies in Biotechnology & Drugs industry 31 other companies have achieved lower Total Debt to Equity for Trailing Twelve Months Period than Actavis Plc. While Total Debt to Equity for Trailing Twelve Months Period total ranking has improved so far to 1976, from total ranking in previous quarter at 1993.

What is Debt to Equity Ratio?
ACT Charts and Quotes
Total Debt to Equity ACT in the most recent quarter
Total Debt to Equity for Trailing Twelve Months Period Company Ranking
Within: No.
Industry # 32
Sector # 235
S&P 500 # 1969


Total Debt to Equity for Trailing Twelve Months Period Statistics
High Average Low
1.39 0.6 0.07
(Sep. 30, 2013)   (Dec 31 2013)




Companies with similar average Total Debt to Equity for Trailing Twelve Months Period for 12 months ending Sep. 30, 2015, within Biotechnology & Drugs Industry Total Debt to Equity for Trailing Twelve Months Period
American Bio Medica Corp  1.60 
Teligent, Inc.  1.45 
Nbty Inc  1.45 
Teligent, Inc.  1.45 
Windtree Therapeutics Inc  1.38 
Halozyme Therapeutics, Inc.  1.22 
Catalyst Biosciences, Inc.  0.96 
Microbot Medical Inc.  0.92 
Gilead Sciences, Inc.  0.88 
Chromadex Corp.  0.83 
Albany Molecular Research Inc  0.83 
Pdl Biopharma, Inc.  0.82 
Amgen Inc.  0.76 
Nanostring Technologies Inc  0.71 
Trovagene, Inc.  0.64 
Actavis Plc  0.60 
Spotlight Innovation Inc.  0.59 
Acorda Therapeutics Inc  0.53 
Neuralstem, Inc.  0.52 
Allergan Plc  0.51 
Agenus Inc  0.50 
Curis Inc  0.50 
Quidel Corp  0.49 
Qiagen Nv  0.45 
Emergent Biosolutions Inc.  0.45 
Fate Therapeutics Inc  0.43 
Biocryst Pharmaceuticals Inc  0.40 
Alliance Bioenergy Plus, Inc.  0.39 
Aytu Bioscience, Inc  0.36 
Gtx Inc  0.36 


             
Economy


Advance Monthly Sales

Consumer Price Index CPI

Producer Price Index PPI

Retail Inventories

Personal Income

Gross Domestic Product GDP

Money Supply

Industrial Production

Productivity

Employment Situation

US International Trade

Factory Orders

Durable Goods

Construction Spending

Housing Starts

Vehicle Unit Sales

Stocks


Event Calendar

GLLX's Profile

Stock Price

GLLX's Financials

Business Description

Fundamentals

Charts & Quotes

GLLX's News

Suppliers

GLLX's Competitors

Customers & Markets

Economic Indicators

GLLX's Growth

Company Segments

Screening


Stock Performance

Growth Rates

Profitability

Valuation

Dividend

Financial Strength

Efficiency

Largest Companies

Management Effectivness

Industries


At a Glance

Performance

Growth Rates

Profitability

Valuation

Financial Strength

Markets


At a Glance

Stocks

Indices

Sectors & Industries

Financials

Commodities

Currencies

News


At a Glance

Stocks

Economy

Industries

Other

Help


Sitemap

Advertise

About us

Glossary


Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.  Free Stock Market News Feeds
   Copyright © 2019 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

To view Intraday Stock Data Java must be installed. Java content may be prohibited by the security software, to see the stock quotes, choose "allow content from this page" option. Stock Price, historical and current end-of-day data provided by eoddata. Intraday data delayed per exchange requirements. S&P/Dow Jones Indices (SM) from Barchart and Eoddata. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071